MacroGenics-Logo-(transparent-background).png
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
March 07, 2024 16:01 ET | MacroGenics, Inc.
Presentation of preliminary data from TAMARACK Phase 2 study of vobra duo in mCRPC patients expected at ASCO 2024Initiation of Phase 1 study of MGC026, MacroGenics' first topoisomerase I...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
September 05, 2023 07:00 ET | MacroGenics, Inc.
ROCKVILLE, MD, Sept. 05, 2023 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
February 13, 2023 17:20 ET | MacroGenics, Inc.
Twelve of 42 patients (28.6%) in metastatic castration-resistant prostate cancer (mCRPC) cohort achieved ≥ 50% prostate-specific antigen (PSA) reduction (PSA50), including 9 (21.4%) who achieved ≥ 90%...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces MGD019 Publication in Cell Reports Medicine
December 22, 2020 11:35 ET | MacroGenics, Inc.
ROCKVILLE, MD, Dec. 22, 2020 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics-Logo-(transparent-background).png
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule
December 18, 2020 07:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, Dec. 18, 2020 (GLOBE NEWSWIRE) --   MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
Inotiv_Logo_CMYK.png
Inotiv Launches Website for Newly Unified Contract Research Services
February 12, 2020 09:18 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company” or “Inotiv”), is pleased to announce the launch of its new...
basi +seventhwave.jpg
BASi Acquires the Smithers Avanza Toxicology Services Business Unit to Support Growing Toxicology Business and Broaden Scientific Talent
May 01, 2019 09:30 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., May 01, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc., (NASDAQ:BASI) (“BASi” or the “Company”) today announced its acquisition of the Smithers Avanza Toxicology Services...
IonSense Introduces the 3+D MicroPlate-96 Screening Plate; Will Be Presented at the American Society for Mass Spectrometry Annual Conference
May 20, 2010 08:30 ET | IonSense, Inc.
SAUGUS, MA--(Marketwire - May 20, 2010) -  IonSense, Inc. today introduced the 3+D MicroPlate-96 Screening Plate to accelerate the rapid screening of samples for food safety, pharmaceutical...
IonSense Introduces 3+D Scanner for Open Air Surface Analysis
February 24, 2010 08:15 ET | IonSense, Inc.
SAUGUS, MA--(Marketwire - February 24, 2010) - IonSense, Inc. today announced the availability of the 3+D Scanner for rapid chemical analysis of surfaces. The 3+D Scanner is interfaced to the...